CEO Spotlight: Heritage Cannabis

Today, we are lucky to have Heritage Cannabis CEO David Schwede with us. During the last year, the company has reported impressive growth and we are bullish on the direction the company is heading. We believe Heritage Cannabis is flying under the radar and hope this interview can help answer the questions that our readers have.

Click Here To Download A FREE Report On Heritage Cannabis

1. During the last year, Heritage Cannabis has recorded impressive growth and has entered several new markets. Can you please tell our readers about the business and the markets it is focused on?
   • At this stage we are multi-pronged, as we are solidifying our position in the Canadian recreational space (currently a top 20 player), establishing ourselves on the largest 3^rd party medical platforms in the country and selectively selecting US states to establish our brand equity while leveraging our core product creation/innovation expertise

2. When compared to other cannabis operators, Heritage Cannabis seems to have figured out how to be more profitable. How has the company been able to grow the business so efficiently?
   • I’m not sure if we consider it being “figured out”, we haven’t had access to the significant sums of capital that our competitors have had, so we focused on building a business that operates in the cannabis sector vs building a cannabis company. Building a sound business should be the goal of every company.
   • Our scarce resource has been capital, as such we treat every dollar with a lot of scrutiny to ensure we can maximize the benefit of the capital outlay.
   • The marketplace is tough given the price compression, inability to effectively market like other CPG product and the tax environment – as result we focus on producing products that consumers want and at a ROI that ties into our overall strategy.
   • The other piece that we focus on is headcount and cost control – we have historically done more with less and our people are core to our success. We continue to focus on this mantra.

3. Heritage Cannabis offers a large suite of products in Canada and has taken a unique approach to capturing market share. Can you please explain the company’s strategy to capture a significant amount of market share in the provinces it enters?
   • Without giving away our overall strategy – we are now in every province and every product vertical except beverages. We have an overall brand strategy and product roadmap that allows us to make sure all consumers can target and get the product that makes the most sense for them.
   • Product innovation and quality is at our core, that is what we focus in each province

4. Growing premium cannabis at scale is a much more challenging process than many operators expected. How has Heritage Cannabis been able to avoid such challenges and how has this benefited the business?
   • While we don’t grow internally, we are continually focused on either ensuring our methodology is applied with our growers or we are very strategic in sourcing the right material for a specific product. We can accomplish this because of our people and the internal production models we have created for our products.
   • Growing and extracting good cannabis to make great products is very difficult. Many industry players failed to recognize how hard it is to create products, there are a few of us in the industry that I look to as peers and as the market refines its taste and cannabis perceptions I believe there will be even less but we are well positioned for it when the market matures.

5. Heritage Cannabis is highly focused on the North American market. Can you tell us some of the most significant potential catalysts for growth?
   • Moving into strategic markets in the US to create brand equity on an asset light basis will be a core strategy in the near future, this will add strong growth potential given the overall size of the market.
   • Continued refinement and penetration in the Canadian market will continue. We continue to find white space and believe the quality of our products will stand out in the market

6. The last year has been a significant growth phase for the company. Where do you see the business going from here?
   • We are continually looking ahead. Our growth and history suggests we have been nimble and quick to be able to move in line or in some instances ahead of the market with limited resources. Given we have positioned the company to be financially stable, we are looking at a number of options to diversify and grow the business further.

7. At current levels, Heritage Cannabis is trading at a huge discount to its peers, and we find the valuation to be attractive. Are there any parts of the business that are completely misunderstood by the market?
   • We agree on the valuation piece. To be honest, those that have attracted significant sums of capital and investor attention in the past simply haven’t performed well either because of bloated businesses or product quality or ill-timed strategic moves and as a result many investors paint all cannabis companies with the same brush.
   • We continue to reach out and tell our story. Generally, most if not all our conversations end with “wow, why haven’t I heard about you before”. While that is a great comment, we believe investors will have to look at the space and find the good companies in the space not the largest or those that have a sound platform and strategy. We believe the tide will turn as investors always want exposure to good companies that are growing.
   • We remain early days in the cannabis sector, we believe in the plant both medically and recreationally. A lot of headwinds have been regulatory in nature which we all know about…taxes, inability to market, product limitations and our hope is many of those will be fixed soon with the current government review. That said, once those are fixed we believe we will have even more growth while the companies that are “broken” will simply remain slightly less “broken”.
   • Overall the cannabis sector remains a growth market and will be for a while. It’s a matter of finding the companies that can capitalize on that without continually eroding significant amounts of capital. We believe we have demonstrated that we are one of those companies.

Click Here To Download A FREE Report On Heritage Cannabis

If you are interested in learning more about Heritage Cannabis, please send an email to suppport@technical420.com.with the subject “Heritage Cannabis” to be added to our distribution list.

Company Relationship Disclosure

T420 is responsible for the T420 opinions provided in this disclosure except all sources or information provided by other parties were not verified or authenticated and T420 does not undertake to confirm or substantiate or be responsible for such information provided by other parties.

Any Content posted regarding a Profiled Issuer is not a solicitation or recommendation to buy, sell or hold securities. We cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change, without notice. We do not, nor are we under any obligation to undertake due diligence or investigation or authenticate and verify whatsoever regarding Profiled Issuers or any Content posted in relation thereto and we do not receive any verification from the Profiled Issuer regarding the Content we disseminate. Similarly, while we endeavor to facilitate the provision of quality information, we are not responsible for any loss or damages caused or alleged to have been caused by its use nor verify or authenticate or update such information.

Pursuant to an agreement between Spotlight Media Corp and Heritage Cannabis (CANN) we have been hired for a period of 90 days beginning December 1, 2022 and ending March 1, 2023 to publicly disseminate information about CANN including on the Website and other media including Facebook and Twitter. We are being paid $3,000 per month by CANN and were paid “ZERO” shares of unrestricted or restricted common shares. We plan to sell the “ZERO” shares of CANN that we hold during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of CANN in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

This article contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “expects”, “does not expect”, “is expected”, “believes”, “intends”, “anticipates”, “does not anticipate”, “believes” or variations of these words, expressions or statements, that certain actions, events or results “may”, “could”, “would”, “might” or “will be” taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, state, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate and expand the Company’s facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal, state and provincial legalization, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company’s limited operating and profitability track record; dependence on management; the Company’s need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the impact of the Russia-Ukraine conflict on the global economy; the continued impact of the COVID-19 pandemic; and the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers. These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company’s efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws.

Share

Tags

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Top Stories